✦ LIBER ✦

A randomized trial of Melphalan alone versus combination chemotherapy in advanced ovarian cancer

✍ Scribed by J.F.G. Sturgeon; S. Fine; M.K. Gospodarowicz; A.J. Dembo; H.A. Bean; R.S. Bush; F.A. Beale; J.G. Herman; J.F. Pringle; G.M. Thomas

Book ID: 119051987
Publisher: Elsevier Science
Year: 1980
Tongue: English
Weight: 96 KB
Volume: 10
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(80)90134-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy of advanced lun

Combination chemotherapy of advanced lung cancer. A randomized trial

✍ Heine H. Hansen; Oleg S. Selawry; Richard Simon; David T. Carr; C. E. van Wyk; R 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Tamoxifen in combination with cytotoxic

Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial

✍ Peter E. Schwartz; Joseph T. Chambers; Ernest I. Kohorn; Setsuko K. Chambers; He 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

Tamoxifen in combination with cytotoxic

Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer: A prospective randomized trial

✍ P.E. Schwartz; J.T. Chambers; E.I. Kohorn; S.K. Chambers; H. Weitzman; I.M. Voyn 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Adriamycin versus methotrexate in five-d

Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial

✍ Hyman B. Muss; Douglas R. White; Frederick Richards II; M. Robert Cooper; John J 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Chemotherapy of advanced breast cancer:

Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination

✍ Rubens, R D; Knight, R K; Hayward, J L 📂 Article 📅 1975 🏛 Nature Publishing Group 🌐 English ⚖ 832 KB

Advanced ovarian carcinoma: A prospectiv

Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques; J. Almeida Ricardo 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

Fifty-seven evaluable patients with advanced ovarian carcinoma were randomized to receive either a combination of hexamethylmelamine, cyclophosphamide, methotrexate and 5-fluorouracil (Hexa-CAF) or high-dose cyclophosphamide alone given intravenously intermittently. Objective responses were seen in